Evaxion Biotech A/S

1.81
-0.13 (-6.70%)
At close: Mar 03, 2025, 3:59 PM
1.89
4.25%
After-hours: Mar 03, 2025, 04:00 PM EST

Evaxion Biotech A/S Ratios Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
PE Ratio -1.06 -2.26 -4.39 -13.33 -17.89 -42.88 n/a
PEG Ratio 0.06 0.10 -0.12 -0.39 -0.13 n/a n/a
PS Ratio 320.92 n/a n/a n/a n/a n/a n/a
PB Ratio -4.95 -0.72 -2.14 28.45 21.39 -254.93 n/a
P/FCF Ratio -1.32 -2.01 -4.62 -15.61 -28.26 -118.79 n/a
P/OCF Ratio -1.32 -2.03 -4.91 -16.1 -28.5 -119.21 n/a
OCF/S Ratio -242.34 n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio -2.3 -0.03 -0.07 0.00 0.00 -9.31 0.06
Quick Ratio 1.18 4.38 8.47 2.59 6.36 1.03 9.04
Current Ratio 1.18 3.71 8.03 1.18 6.36 0.89 9.04
Asset Turnover 0.01 n/a n/a n/a n/a n/a n/a
Interest Coverage -24.75 -16.75 -28.23 -74.3 -8.89 -8.06 n/a
Return on Equity (ROE) 4.68 0.32 0.49 -2.13 -1.2 5.95 n/a
Return on Assets (ROA) -1.72 0.39 -0.61 -1.26 -1.01 -0.65 n/a
Return on Capital (ROIC) -3.82 0.40 -0.72 -2.35 -1.16 6.20 n/a
Dividend Yield n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin 99.85% n/a n/a n/a n/a n/a n/a
Net Profit Margin -30.31K% n/a n/a n/a n/a n/a n/a
Pretax Profit Margin -31.39K% n/a n/a n/a n/a n/a n/a
Operating Profit Margin -30.41K% n/a n/a n/a n/a n/a n/a
FCF Margin -24.35K% n/a n/a n/a n/a n/a n/a
EBITDA Margin -29.32K% n/a n/a n/a n/a n/a n/a